The
road
of
acceptance
oncologic
thermotherapy/hyperthermia
as
a
synergistic
modality
in
combination
with
standard
therapies
is
still
bumpy.
This
partially
due
to
the
lack
level
I
evidence
from
international,
multicentric,
randomized
clinical
trials
including
large
patient
numbers
and
long
term
follow-up.
Therefore
we
need
more
EVIDENCE
trials,
HARMONISATION
global
for
existing
technologies
common
language
understood
by
all
stakeholders
INNOVATION
fields
biology,
clinics
technology
move
forward.
main
focus
this
reprint.
In
reprintyou
find
carefully
selected
peer-reviewed
contributions
Africa,
America,
Asia,
Europe.
published
papers
leading
scientists
over
world
covering
broad
range
timely
research
topics
might
also
help
strengthen
thermotherapy
on
level.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2023,
Номер
11
Опубликована: Фев. 16, 2023
When
hydrogel
materials
with
excellent
biocompatibility
and
biodegradability
are
used
as
new
drug
carriers
in
the
treatment
of
cancer,
they
confer
following
three
advantages.
First,
can
be
a
precise
controlled
release
systems,
which
continuously
sequentially
chemotherapeutic
drugs,
radionuclides,
immunosuppressants,
hyperthermia
agents,
phototherapy
agents
other
substances
widely
cancer
through
radiotherapy,
chemotherapy,
immunotherapy,
hyperthermia,
photodynamic
therapy
photothermal
therapy.
Second,
have
multiple
sizes
delivery
routes,
targeted
to
different
locations
types
cancer.
This
greatly
improves
targeting
thereby
reducing
dose
drugs
improving
effectiveness.
Finally,
intelligently
respond
environmental
changes
according
internal
external
stimuli
so
that
anti-cancer
active
remotely
released
on
demand.
Combining
abovementioned
advantages,
transformed
into
hit
field
treatment,
bringing
hope
further
increase
survival
rate
quality
life
patients
Advanced Healthcare Materials,
Год журнала:
2023,
Номер
13(1)
Опубликована: Сен. 6, 2023
Sonodynamic
therapy
(SDT)
has
emerged
as
a
highly
effective
modality
for
the
treatment
of
malignant
tumors
owing
to
its
powerful
penetration
ability,
noninvasiveness,
site-confined
irradiation,
and
excellent
therapeutic
efficacy.
However,
traditional
SDT,
which
relies
on
oxygen
availability,
often
fails
generate
satisfactory
level
reactive
species
because
widespread
issue
hypoxia
in
tumor
microenvironment
solid
tumors.
To
address
this
challenge,
various
approaches
are
developed
alleviate
improve
efficiency
SDT.
These
strategies
aim
either
increase
supply
or
prevent
exacerbation,
thereby
enhancing
effectiveness
In
view
this,
current
review
provides
an
overview
these
their
underlying
principles,
focusing
circulation
from
consumption
external
supply.
The
detailed
research
examples
conducted
using
combination
with
SDT
also
discussed.
Additionally,
highlights
future
prospects
challenges
hypoxia-alleviated
along
key
considerations
clinical
applications.
include
development
efficient
delivery
systems,
accurate
methods
detection,
exploration
therapies
optimize
outcomes.
Cancers,
Год журнала:
2023,
Номер
15(5), С. 1394 - 1394
Опубликована: Фев. 22, 2023
(1)
Background:
Mild
hyperthermia
(mHT,
39-42
°C)
is
a
potent
cancer
treatment
modality
when
delivered
in
conjunction
with
radiotherapy.
mHT
triggers
series
of
therapeutically
relevant
biological
mechanisms,
e.g.,
it
can
act
as
radiosensitizer
by
improving
tumor
oxygenation,
the
latter
generally
believed
to
be
commensurate
result
increased
blood
flow,
and
positively
modulate
protective
anticancer
immune
responses.
However,
extent
kinetics
flow
(TBF)
changes
oxygenation
are
variable
during
after
application
mHT.
The
interpretation
these
spatiotemporal
heterogeneities
currently
not
yet
fully
clarified.
(2)
Aim
methods:
We
have
undertaken
systematic
literature
review
herein
provide
comprehensive
insight
into
potential
impact
on
clinical
benefits
therapeutic
modalities
such
radio-
immuno-therapy.
(3)
Results:
mHT-induced
increases
TBF
multifactorial
differ
both
spatially
time.
In
Pharmaceutics,
Год журнала:
2023,
Номер
15(10), С. 2406 - 2406
Опубликована: Сен. 30, 2023
The
main
concept
of
radiosensitization
is
making
the
tumor
tissue
more
responsive
to
ionizing
radiation,
which
leads
an
increase
in
potency
radiation
therapy
and
allows
for
decreasing
dose
concomitant
side
effects.
Radiosensitization
by
metal
oxide
nanoparticles
widely
discussed,
but
range
mechanisms
studied
not
sufficiently
codified
often
does
reflect
ability
nanocarriers
have
a
specific
impact
on
cells.
This
review
focused
magnetic
iron
while
they
occupied
special
niche
among
prospective
radiosensitizers
due
unique
physicochemical
characteristics
reactivity.
We
collected
data
about
possible
molecular
underlying
radiosensitizing
effects
(IONPs)
approaches
their
therapeutic
efficacy
variable
modifications.
Cancers,
Год журнала:
2024,
Номер
16(3), С. 505 - 505
Опубликована: Янв. 24, 2024
Despite
significant
advancements
in
the
development
of
novel
therapies,
cancer
continues
to
stand
as
a
prominent
global
cause
death.
In
many
cases,
cornerstone
standard-of-care
therapy
consists
chemotherapy
(CT),
radiotherapy
(RT),
or
combination
both.
Notably,
hyperthermia
(HT),
which
has
been
clinical
use
last
four
decades,
proven
enhance
effectiveness
CT
and
RT,
owing
its
recognized
potency
sensitizer.
Furthermore,
HT
exerts
effects
on
all
steps
cancer–immunity
cycle
impact
key
oncogenic
pathways.
Most
recently,
there
noticeable
expansion
research
related
treatment
options
involving
immunotherapy
(IT)
targeted
(TT),
trend
also
visible
pipelines
pharmaceutical
companies.
However,
potential
results
arising
from
these
innovative
therapeutic
approaches
with
remain
largely
unexplored.
Therefore,
this
review
aims
explore
oncology
major
companies,
primary
objective
identifying
principal
targets
forthcoming
therapies
that
have
be
advantageous
for
patients
by
specifically
targeting
molecular
pathways
involved
HT.
The
ultimate
goal
is
pave
way
future
initiatives
trials
harness
synergy
between
emerging
IT
TT
medications
when
used
conjunction
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Год журнала:
2024,
Номер
1879(4), С. 189109 - 189109
Опубликована: Май 14, 2024
The
clinical
translation
of
the
nanoparticle
(NP)-based
anticancer
therapies
is
still
unsatisfactory
due
to
heterogeneity
enhanced
permeability
and
retention
(EPR)
effect.
Despite
promising
preclinical
outcome
pharmacological
EPR
enhancers,
their
systemic
toxicity
can
limit
application.
Hyperthermia
(HT)
presents
an
efficient
tool
augment
by
improving
tumor
blood
flow
(TBF)
vascular
permeability,
lowering
interstitial
fluid
pressure
(IFP),
disrupting
structure
extracellular
matrix
(ECM).
Furthermore,
HT-triggered
intravascular
release
approach
overcome
In
contrast
approaches,
HT
safe
be
focused
cancer
tissues.
Moreover,
conveys
direct
anti-cancer
effects,
which
improve
efficacy
agents
encapsulated
in
NPs.
However,
application
challenging
heterogeneous
distribution
temperature
within
tumor,
length
treatment
complexity
monitoring.
International Journal of Hyperthermia,
Год журнала:
2025,
Номер
42(1)
Опубликована: Янв. 12, 2025
This
review
was
written
to
be
included
in
the
Special
Collection
'Therapy
Ultrasound:
Medicine's
Swiss
Army
Knife?'
The
purpose
of
this
is
provide
basic
presentation
and
interpretation
fundamentals
hyperthermia
biology,
as
it
pertains
uses
therapeutic
ultrasound.
are
presented
but
setting
a
translational
view
toward
future.
Subjects
that
require
future
research
development
highlighted.
effects
time
temperature
dependent.
Because
intra-tumoral
temperatures
non-uniform
tumors,
one
has
account
for
differential
biologic
different
parts
tumor
occur
simultaneously
during
after
hyperthermia.
Cancers,
Год журнала:
2023,
Номер
15(3), С. 655 - 655
Опубликована: Янв. 21, 2023
Thermal
therapies
are
under
investigation
as
part
of
multi-modality
strategies
for
the
treatment
pancreatic
cancer.
In
present
study,
we
determined
kinetics
thermal
injury
to
cancer
cells
in
vitro
and
evaluated
predictive
models
injury.
Cell
viability
was
measured
two
murine
cell
lines
(KPC,
Pan02)
a
normal
fibroblast
(STO)
line
following
heating
range
42.5-50
°C
3-60
min.
Based
on
data,
kinetic
parameters
were
used
predict
extent
heat-induced
damage.
Of
three
considered
this
Arrhenius
model
with
time
delay
provided
most
accurate
prediction
(root
mean
square
error
=
8.48%)
all
lines.
Pan02
STO
resistant
susceptible
hyperthermia
treatments,
respectively.
The
presented
data
may
contribute
studies
investigating
use
inform
design
planning
strategies.